Fermented Millet Porridge, Gut Microbiota and Inflammation Status in Women
- Conditions
- Microbiome, HumanInflammation
- Interventions
- Other: Fermented porridge
- Registration Number
- NCT05299970
- Lead Sponsor
- Institut de Recherche en Sciences de la Sante, Burkina Faso
- Brief Summary
Maternal undernutrition concerns 10-19% of women of reproductive age globally, the vast majority of which live in sub Saharan Africa and south Asia. Recommendations for nutritional interventions to tackle the problem range from per-pregnancy supplementation to upstream interventions targeting women of reproductive age before conception. To render the latter interventions cost-effective and sustainable, experts recommend to focus on food processing that leads to an enhanced nutrient content. One such method, which has been known and practiced for centuries in diverse societies, is fermentation. Traditionally fermented foods are diverse, widespread and highly appreciated in Burkina Faso. The present study aims to investigate the effect of fermented millet porridge on gut microbiota diversity, stool short chain fatty acid concentration and inflammation markers level in women of reproductive age living in rural Burkina Faso.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 80
Participant are
- 18 to 49 years old
- Resident in the study area and do not plan to move within 5 months following the start of the study
- Are not on antibiotic treatment on inclusion and have not been in the previous 3 weeks.
- Do not suffer from any pathology that could interfere with their diet.
- Have no known allergy to pearl millet or its derivatives
- Agree to sign a consent to participate in the study-
- Women under 18 or over 49
- Women not consuming pearl millet porridge due to allergy or food preference
- Women planning to move from the study area within 5 months of the start of the study
- Women with serious illnesses that may interfere with their diet
- Women on antibiotic treatment or at the time of inclusion or having been in the previous 3 weeks.
- In addition, women who will benefit from antibiotic therapy during the study will be excluded from the analysis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description fermented porridge Fermented porridge this study arm participant will consume fermented millet porridge, daily Non-fermented porridge Fermented porridge this study arm participants will consume non-fermented millet porridge, daily
- Primary Outcome Measures
Name Time Method Gut microbiota diversity 0 to 13 weeks gut microbiota alpha and beta diversity
Concentration of inflammation markers in blood and stool 0 to 13 weeks Concentration of IL1-beta, IL 8, IL 6, IL 33, TNF-alpha, lipocalin 2, myeloperoxidase, calprotectin
- Secondary Outcome Measures
Name Time Method Concentration of short chain fatty acid in stool 0 to 13 weeks Concentration of C2-C8 fatty acids in stool
relative abundance of bacterial and fugal micro-organisms in millet dough and porridge 2 to 8 weeks Count of microbial populations
concentration of macronutrients in millet dough and porridge 2 to 8 weeks Levels of carbohydrates, lipids, protein, dietary fiber and phytates
Concentration of Ferritin in plasma 0- to 13 weeks Ferritin levels in Plasma
Number of participant with anemia 0 to 13 weeks hemoglobin concentration in grams per deciliter
Trial Locations
- Locations (1)
IRSS-DRO
🇧🇫Bobo-Dioulasso, Houet, Région Des hauts-Bassins, Burkina Faso